Wellington Partners Holds First Close of Life Science Fund at €70M

Venture Capital firm Wellington Partners has held the first closing of new life science fund at €70m.

Backers include international investors from Germany, Switzerland, Austria, Benelux, France, the UK, the US and the Middle East.
Main backers include the European Investment Fund via its ERP-EIF Dachfonds, LfA Foerderbank Bayern, Austria Wirtschaftsservice GmbH and several large family offices.

With a target size of € 120m, Wellington Partners IV Life Science Fund will focus on investing in innovative companies in the areas of medical devices, diagnostics and biotechnology on a pan-European basis.
The firm’s life science team include General Partners Rainer Strohmenger, Erich Schlick, Regina Hodits, Harald Keller, Ernst Mannheimer and Rolf Dienst.

Wellington Partners has more than € 800m under management and offices in Munich, London and Zurich.



Join the discussion